| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/18/2010 | US20100041651 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/18/2010 | US20100041072 Process for identifying a ligand that binds to the nep binding site for the smr1 pentapeptide |
| 02/18/2010 | US20100040711 Zinc-carnosine -based treatment for non ulcer (functional ) dyspepsia & irritable bowel syndrome in humans and other animals |
| 02/18/2010 | US20100040698 Prophylactic and/or therapeutic agent for functional gastrointestinal disorders |
| 02/18/2010 | US20100040628 Indoprofen derivatives for promoting bone growth |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040595 Xylanses for animal feed |
| 02/18/2010 | US20100040592 Lipase-containing composition and methods of use thereof |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | CA2734082A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 02/18/2010 | CA2733922A1 A crystalline form of 4-(5-{(1r)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 02/18/2010 | CA2733920A1 A new crystalline form of 4-(5-{(1r)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | CA2733397A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 02/18/2010 | CA2732892A1 Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration |
| 02/17/2010 | EP2154139A1 Bicyclic heterocyclic compound |
| 02/17/2010 | EP2154131A1 G protein-coupled receptor inhibitor and pharmaceutical product |
| 02/17/2010 | EP2153870A1 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| 02/17/2010 | EP2153839A1 Composition for prevention and/or treatment of peptic ulcer |
| 02/17/2010 | EP2153838A1 Anti-norovirus agent, and composition comprising the same |
| 02/17/2010 | EP2153831A1 Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient |
| 02/17/2010 | EP2153736A1 Novel leukotriene receptor antagonist |
| 02/17/2010 | EP2152263A1 Compositions useful for treating gastroesophageal reflux disease |
| 02/17/2010 | EP1511737B1 Aryloximes |
| 02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
| 02/17/2010 | CN100589839C Polypeptide and medicament composition containing polypeptide |
| 02/16/2010 | US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy |
| 02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/16/2010 | US7662817 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 02/16/2010 | US7662799 Powder of amino acids and method for producing the same |
| 02/16/2010 | US7662798 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| 02/16/2010 | US7662768 Transdifferentiation of pancreatic acinar cells |
| 02/16/2010 | US7662633 Method of screening for inhibitors of osteopontin |
| 02/16/2010 | US7662380 ZAQ ligand-1 antibodies and uses thereof |
| 02/16/2010 | US7662366 Administering granulocyte colony stimulating factor; treating type 2 diabetes in simple, safe manner |
| 02/16/2010 | US7662365 Polymer conjugates of opioid antagonists |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/16/2010 | CA2429109C Anti-inflammatory agents |
| 02/16/2010 | CA2422267C Drying method for selectively removing volatile components from wet coatings |
| 02/16/2010 | CA2410939C Materials and methods for the treatment of gastroesophageal reflux disease |
| 02/16/2010 | CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 02/16/2010 | CA2308551C Phenanthroline derivatives |
| 02/11/2010 | WO2010017403A2 Therapeutic compositions, devices and methods for observing treated tissues |
| 02/11/2010 | WO2010016590A1 Therapeutic or prophylactic agent for generalized pain syndrome |
| 02/11/2010 | WO2010016552A1 Therapeutic agent for irritable bowel syndrome |
| 02/11/2010 | WO2010015800A1 Chewable formulation comprising alginate, bicarbonate and carbonate |
| 02/11/2010 | WO2010015794A1 Novel polymorphic forms of tegaserod |
| 02/11/2010 | WO2010015792A1 Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors |
| 02/11/2010 | WO2010015655A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists |
| 02/11/2010 | WO2009157858A8 Use of cyclolignans for the treatment of a hyperactive immune system |
| 02/11/2010 | WO2009141532A3 Derivatives of 1,5-diphenyl pyrrole-3-carboxamide, preparation thereof and use of same as cannabinoid cb1 receptor antagonists |
| 02/11/2010 | US20100036132 Process for the preparation of opiod modulators |
| 02/11/2010 | US20100035992 Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies |
| 02/11/2010 | US20100035984 Use of an antibacterial compound which is derived from alliaceae, as a natural additive in animal feed |
| 02/11/2010 | US20100035954 Acid addition salts of muscarinic receptor antagonists |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/11/2010 | US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
| 02/11/2010 | US20100035929 Unnatural dispyrin analogues, preparation and uses thereof |
| 02/11/2010 | US20100035921 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 02/11/2010 | US20100035918 Imidazolone Compounds and Methods of Making and Using the Same |
| 02/11/2010 | US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases |
| 02/11/2010 | US20100035893 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
| 02/11/2010 | US20100035880 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 02/11/2010 | US20100035850 Method of treatment for inflammatory bowel disease |
| 02/11/2010 | US20100035849 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 02/11/2010 | US20100035848 Therapy for disorders of the proximal digestive tract |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100034838 Transdermal Administration of Active Agents for Systemic Effect |
| 02/11/2010 | US20100034823 Crystalline anti-hTNFalpha antibodies |
| 02/11/2010 | US20100034798 Composition and method of use for intestinal health |
| 02/11/2010 | DE202008016879U1 Antidiarrhoikum Antidiarrheal |
| 02/11/2010 | CA2732887A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists |
| 02/10/2010 | EP2151500A1 Branched -glucan, -glucosyltransferase producing the same, method for producing the same and use thereof |
| 02/10/2010 | EP2151451A1 Composition for preventing or treating lung disease |
| 02/10/2010 | EP2151436A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 02/10/2010 | EP2151242A1 Use of oxygen for treatment of illnesses of the mucous membrane of the intestinal channel |
| 02/10/2010 | EP2151236A1 G-protein-conjugated receptor agonist |
| 02/10/2010 | EP2150272A1 Means and methods for enhancing weight gain in poultry |
| 02/10/2010 | EP1701951B1 Modulators of peripheral 5-ht receptors |
| 02/10/2010 | EP1525191B1 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/10/2010 | EP1499331B1 Salt solution for colon cleansing |
| 02/10/2010 | EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/10/2010 | CN100588404C Chinese traditional medicine compound injection and preparation method thereof |
| 02/10/2010 | CN100588397C Armillarisin A solution preparation and its preparing method |
| 02/09/2010 | US7659407 Pharmaceutical compounds |
| 02/09/2010 | US7659402 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds |
| 02/09/2010 | US7659303 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 02/09/2010 | US7659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 02/09/2010 | US7659293 α-Amino-N-hydroxy-acetamide derivatives |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | US7659263 (E)-3-[4-({1-[(11-cyclohexyl-8-methoxy-4,5-dihydro-6-oxa-1-thia-3b-azabenzo[e]cyclopenta[a]azulene-2-carbonyl)amino]cyclobutanecarbonyl}amino)phenyl]acrylic acid; RNA-dependent RNA polymerase inhibitory activity; hepatitis C |
| 02/09/2010 | US7658918 Stable digestive enzyme compositions |
| 02/09/2010 | CA2557576C Novel benzothiazepine and benzothiepine compounds |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 02/09/2010 | CA2438704C Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 02/09/2010 | CA2413061C Serine protease inhibitors |